Mercer Global Advisors’s Jazz Pharmaceuticals JAZZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$323K Buy
3,044
+1,332
+78% +$141K ﹤0.01% 1782
2025
Q1
$213K Buy
1,712
+71
+4% +$8.82K ﹤0.01% 1938
2024
Q4
$202K Sell
1,641
-1,686
-51% -$208K ﹤0.01% 1968
2024
Q3
$371K Sell
3,327
-158
-5% -$17.6K ﹤0.01% 1514
2024
Q2
$372K Buy
3,485
+1,187
+52% +$127K ﹤0.01% 1470
2024
Q1
$277K Sell
2,298
-365
-14% -$44K ﹤0.01% 1609
2023
Q4
$328K Sell
2,663
-112
-4% -$13.8K ﹤0.01% 1554
2023
Q3
$359K Buy
2,775
+79
+3% +$10.2K ﹤0.01% 1418
2023
Q2
$334K Sell
2,696
-632
-19% -$78.3K ﹤0.01% 1452
2023
Q1
$487K Sell
3,328
-625
-16% -$91.5K ﹤0.01% 1219
2022
Q4
$630K Sell
3,953
-111
-3% -$17.7K ﹤0.01% 1101
2022
Q3
$542K Sell
4,064
-505
-11% -$67.4K ﹤0.01% 1096
2022
Q2
$713K Sell
4,569
-257
-5% -$40.1K ﹤0.01% 984
2022
Q1
$751K Sell
4,826
-1,722
-26% -$268K ﹤0.01% 1027
2021
Q4
$834K Sell
6,548
-599
-8% -$76.3K 0.01% 968
2021
Q3
$931K Sell
7,147
-4,114
-37% -$536K 0.01% 887
2021
Q2
$2M Sell
11,261
-515
-4% -$91.5K 0.02% 571
2021
Q1
$1.94M Sell
11,776
-617
-5% -$101K 0.02% 530
2020
Q4
$2.05M Sell
12,393
-24,223
-66% -$4M 0.03% 414
2020
Q3
$5.22M Sell
36,616
-163
-0.4% -$23.2K 0.08% 192
2020
Q2
$4.06M Buy
36,779
+8,779
+31% +$969K 0.07% 194
2020
Q1
$2.79M Buy
28,000
+24,919
+809% +$2.49M 0.06% 252
2019
Q4
$460K Buy
3,081
+336
+12% +$50.2K 0.01% 760
2019
Q3
$351K Sell
2,745
-82
-3% -$10.5K 0.01% 837
2019
Q2
$403K Buy
2,827
+258
+10% +$36.8K 0.01% 760
2019
Q1
$367K Buy
+2,569
New +$367K 0.01% 749